GENETRONICS BIOMEDICAL CORP.

Company

INOVIO PHARMACEUTICALS, INC.

Filed

January 29, 2003

Accession Number

0000950128-03-000101

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →